HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No OTC High Dose Vit D3 Supplements, Say German Doctors After Infant Overdose Case

Executive Summary

The Drug Commission of the German Medical Association warns against the unsupervised use of high-dose vitamin D3 supplements after the overdose of a seven-month-old German infant.

You may also be interested in...



Vitamin D Supplements And COVID-19: Still No Evidence, No Harm In Doing It Anyway

Two new RCTs cast further doubt on the preventative effects of vitamin D supplementation with regards to COVID-19 infection. Nevertheless, an editorial in the British Medical Journal, where the studies were published, leaves open positive effects for those suffering from vitamin D deficiency, and recommends a daily supplement of up to 2000IU just in case.

UK Vitamin D Overdose Case Not Reflective Of Ordinary Use, Says Industry

A recent case of overdose linked to use of vitamin D supplements is not reflective of how consumers ordinarily use these products, say the UK’s Health and Food Supplements Information Service and Health Food Manufacturer's Association.

Sweden Proposes Maximum Levels For Vitamin D And Iodine In Supplements

Concerned about adverse health effects, Sweden wants to limit the amount of vitamin D and iodine in supplements from January 2024. In setting maximum levels for certain vitamins and minerals, Sweden will join a host of European countries introducing national rules in the absence of direction from the European Commission. 

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel